Independent fund research. Built on SEC filings.

How we research funds

Fund comparison

IBRN vs. SBIO: which is better?

Bottom line

IBRN vs SBIO: the short answer

IBRN (iShares Neuroscience and Healthcare ETF) and SBIO (ALPS Medical Breakthroughs ETF) are quite different portfolios: only about 24% of their top holdings (by weight) are shared.

IBRN is cheaper at 0.47% vs 0.5% — a difference of $3.00 a year per $10,000 invested.

Over one year, SBIO returned +54.2% vs −2.7% for IBRN (reporting dates differ).

Updated Nov 19, 2026

IBRN vs SBIO side by side

IBRNSBIO
TypeETFETF
Fund familyiSharesAlps
CategoryHealth Care SectorHealth Care Sector
Expense ratio0.47%0.5%
Annual cost per $10k$47$50
10-yr cost on $10k (prospectus)$591$628
Max front loadNoneNone
12b-1 fee0%—
1-yr return−2.7%+54.2%
5-yr return (annualized)—+0.7%
10-yr return (annualized)—+5.7%
Best quarter+25.0%+33.9%
Worst quarter−13.5%−30.8%
Net assets (fund)$5.5M$161.8M
Number of holdings7889
Portfolio turnover52%58%
Returns as ofDec 31, 2024Dec 31, 2025

Source: SEC Form N-PORT and fund prospectuses

Year-by-year returns

YearIBRNSBIODifference
2024−2.7%+4.2%−6.8%
2023+1.0%+8.2%−7.2%

Source: Fund prospectus bar charts

Holdings overlap

6 of IBRN's top 25 holdings also appear in SBIO's top 25.

Shared top holdings
HoldingIBRNSBIO
Dianthus Therapeutics Inc5.34%2.64%
Xenon Pharmaceuticals Inc4.87%2.90%
Acadia Pharmaceuticals Inc.4.69%2.35%
Alkermes Public Limited Company4.60%4.48%
Denali Therapeutics Inc3.67%2.13%
Edgewise Therapeutics Inc3.23%2.33%

Source: SEC Form N-PORT

IBRN top 10

  1. BlackRock Funds III: BlackRock Cash Funds: Institutional; SL Agency Shares — 14.64%
  2. Dianthus Therapeutics Inc — 5.34%
  3. Xenon Pharmaceuticals Inc — 4.87%
  4. Praxis Precision Medicines Inc — 4.87%
  5. Acadia Pharmaceuticals Inc. — 4.69%
  6. Arrowhead Pharmaceuticals, Inc. — 4.65%
  7. Alkermes Public Limited Company — 4.60%
  8. Scholar Rock Holding Corp — 4.29%
  9. Biogen Inc. — 4.18%
  10. Neurocrine Biosciences, Inc. — 4.09%

SBIO top 10

  1. Alkermes Plc — 4.48%
  2. Kymera Therapeutics Inc — 4.23%
  3. Celcuity Inc — 3.92%
  4. Mirum Pharmaceuticals Inc — 3.90%
  5. Spyre Therapeutics Inc — 3.68%
  6. Cg Oncology Inc — 3.35%
  7. Apogee Therapeutics Inc — 2.93%
  8. Xenon Pharmaceuticals Inc — 2.90%
  9. Travere Therapeutics Inc — 2.77%
  10. Dianthus Therapeutics Inc — 2.64%

FAQ

What is the difference between IBRN and SBIO?
IBRN (iShares Neuroscience and Healthcare ETF) and SBIO (ALPS Medical Breakthroughs ETF) are quite different portfolios: only about 24% of their top holdings (by weight) are shared. IBRN is cheaper at 0.47% vs 0.5% — a difference of $3.00 a year per $10,000 invested.
Which is cheaper, IBRN or SBIO?
IBRN has the lower expense ratio (0.47%).
Should I own both IBRN and SBIO?
Because their portfolios differ, owning both can add diversification — check how they fit your overall allocation.

Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.